RxSight share price logo

RxSight

NASDAQ: RXST

Small Cap

$6.25

+0.17

(+2.71%)

as on

RxSight Stock Performance

as on August 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.00
    $6.31
    downward going graph

    4.00%

    Downside

    0.96%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.48
    $13.22
    downward going graph

    28.32%

    Downside

    111.52%

    Upside

    downward going graph

RxSight share price movements today

Previous Close
$6.09
Open
$6.12
Volume
1.8M
Market Cap
$286.6M
Day's Low - High
$6.00 - $6.31
52 Week Low - High
$4.48 - $13.22

RxSight Historical Returns

1 Month Return
+ 24.14 %
3 Month Return
+ 21.3 %
1 Year Return
-18.27 %
3 Year Return
-76.7 %
5 Year Return
-41.86 %

RxSight Stock Fundamentals & Key Indicators

Check RxSight market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$286.6M

EPS (TTM)

-1.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.2

Industry PE ratio

-5.547073170731707

PEG Ratio

0.1888141876446427

EBITDA

-43.3M

Revenue (TTM)

127.6M

Profit Margin

77.50%

Return On Equity TTM

-17.35%

RxSight Stock Valuation

Track how RxSight P/E has moved over time to understand its valuation trends.

RxSight in the last 5 years

  • Overview

  • Trends

Lowest (-48.42x)

December 31, 2024

Today (-10.97x)

December 31, 2025

Industry (-5.55x)

December 31, 2025

Highest (-5.25x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -10.97x

RxSight vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of RxSight with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
RxSight image
RxSight
BUY$286.6M-41.86%-6.277.50%NA
Stryker image
Stryker
BUY$130.1B26.77%35.2214.43%102.06%
Edwards Lifesciences image
Edwards Lifesciences
BUY$52.8B-21.88%53.277.98%NA
Medtronic image
Medtronic
BUY$116.1B-30.2%24.1565.02%3.15%
Abbott Laboratories image
Abbott Laboratories
BUY$192.5B-11.49%3611.65%222.88000000000002%
See all

Stock Returns calculator for RxSight Stock including INR - Dollar returns

The RxSight stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

RxSight investment value today

Current value as on today

₹81,267

Returns

-₹18,733

(-18.73%)

Returns from RxSight Stock

-₹25,860 (-25.86%)

Dollar Impact

₹7,127 (+7.13%)

Analyst Recommendation on RxSight Stock

Based on 10 analysts

BUY

10.00%

Buy

70.00%

Hold

20.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for RxSight. Average target price of $7.79

RxSight Share Price Target

Get share price movements and forecasts by analysts on RxSight.

What analysts predicted

19.77%UPSIDE

Target Price

$7.79

Current Price

$6.25

Analyzed by

10 Analysts

Target

$7.79

RxSight target price $7.79, a slight upside of 19.77% compared to current price of $6.25. According to 10 analysts rating.

Indian Investors' Interest in RxSight Stock

Search interest for RxSight Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:40% versus previous 30 day period

RxSight Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
29
34
45
40
37
33
30
32
30
33
Gross Profit
20
24
25
28
28
25
24
25
23
25
Operating Income
-10
-8
-9
-8
-10
-14
-12
-11
-17
-13
EBITDA
-7
-5
-5
-5
-7
-10
-8
-8
-15
-11
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
0
1
0
0
0
0
0
0
0
Income Before Tax
-9
-6
-6
-5
-8
-11
-9
-9
-15
-12
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-9
-6
-6
-5
-8
-11
-9
-9
-15
-12
Net Profit Margin
70.09%
69.51%
55.54%
71.59%
74.76%
74.89%
79.85%
77.48%
76.06%
76.72%

RxSight Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
14
22
49
89
139
134
Gross Profit
-1
1
4
21
53
98
103
Operating Income
-46
-35
-52
-63
-50
-36
-48
EBITDA
130
32
-41
-57
-41
-23
-38
Interest Expense
0
0
3
4
3
0
0
Depreciation
3
4
3
4
4
3
-
Income Before Tax
126
27
-48
-66
-48
-27
-38
Income Tax Expense
0
0
0
0
0
0
0
Net Income
126
27
-48
-66
-48
-27
-38
Net Profit Margin
-81.17%
11.62%
19.99%
43.52%
60.36%
70.71%
76.60%

RxSight Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-6
-6
-5
-8
-11
-9
-9
-15
-12
Operating Cash Flow
-9
-4
0
-4
-8
-4
-1
-1
-10
-9
Investing Cash Flow
24
-115
-9
1
20
14
-9
-9
8
4
Financing Cash Flow
7
111
0
2
0
2
0
1
0
0
Change in Cash
22
-8
-7
0
11
12
-10
-9
-2
-4

RxSight Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
126
27
-48
-66
-48
-27
-38
Operating Cash Flow
-40
-35
-44
-58
-41
-16
-15
Investing Cash Flow
-5
15
-81
39
-22
-99
16
Financing Cash Flow
1
25
137
6
61
123
1
Change in Cash
-45
5
10
-12
-2
7
3

Mutual Funds that own RxSight Stock

Check out the Mutual Funds with significant holdings in RxSight.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.937842%
1637877
Artisan Partners Funds Inc.
3.19138%
1327399
Federated Hermes MDT Series
1.680693%
699055
TIAA-CREF Funds
1.136508%
472711
Fidelity Salem Street Trust
1.013933%
421728
See all

Global Institutional Holdings in RxSight

Funds
Holdings
Vanguard
4.86%
Jeff Osher
4.81%
iShares
3.75%
Xtrackers
3.72%
Roberto Mignone
0.6%
See all

RxSight News & Key Events

    Insights on RxSight

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -15.88M → -12.09M (in $), with an average increase of 31.3% per quarter

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 30.89M → 33.74M (in $), with an average increase of 8.4% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Stryker Corporation has given 18.2% return, outperforming this stock by 97.9%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Edwards Lifesciences Corp has given 9.8% return, outperforming this stock by 44.2%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, RXST stock has moved down by -11.6%

    About RxSight

    RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
    OrganisationRxSight
    Headquarters100 Columbia, Aliso Viejo, CA, United States, 92656
    IndustryMedical Devices
    CEOMr. Aziz Mottiwala M.B.A.
    E-voting on sharesClick here to vote

    Key Management of RxSight

    Name

    Title

    Mr. Oliver Moravcevic

    Vice President of Investor Relations

    Mr. Jim Schindler

    Executive VP & General Counsel

    Ms. Maureen O'Connell

    Executive VP of Clinical & Regulatory Affairs

    Mr. Patrick Cullen

    Executive VP of Quality & Infrastructure Operations

    Mr. Adam Dashe

    Executive Vice President of International

    Dr. Ilya Goldshleger Ph.D.

    Chief Operating Officer

    Dr. Ronald M. Kurtz M.D.

    Chief Medical Officer

    Mr. Mark Wilterding

    Chief Financial Officer

    Mr. Eric J. Weinberg

    Chief Business Development Officer

    Mr. Aziz Mottiwala M.B.A.

    President, CEO & Director

    FAQs

    What is RxSight share price today?

    RxSight share price today is $6.25 as on at the close of the market. RxSight share today touched a day high of $6.31 and a low of $6.00.

    What is the 52 week high and 52 week low for RxSight share?

    RxSight share touched a 52 week high of $13.22 on and a 52 week low of $4.48 on . RxSight stock price today i.e. is closed at $6.25,which is 52.72% down from its 52 week high and 39.51% up from its 52 week low.

    What is RxSight's market capitalisation today?

    RxSight market capitalisation is $0.00T as on .

    How to invest in RxSight Stock (RXST) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for RxSight on INDmoney app. Click on Buy button. You can invest as low as $1.5 in RxSight Shares that will get you 0.2400 shares as per RxSight share price of $6.25 per share as on August 22, 2026 at 1:29 am IST.

    What is the minimum amount required to buy RxSight Stock (RXST) from India?

    Indian investors can start investing in RxSight (RXST) shares with as little as ₹95.685 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹956.85 in RxSight stock (as per the Rupee-Dollar exchange rate as on ). Based on RxSight share’s latest price of $6.25 as on August 22, 2026 at 1:29 am IST, you will get 1.6000 shares of RxSight. Learn more about fractional shares .

    What are the returns that RxSight has given to Indian investors in the last 5 years?

    RxSight stock has given -41.86% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?